vs
VAALCO ENERGY INC（EGY）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
VAALCO ENERGY INC的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.2倍（$91.0M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -25.2%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -4.7%）
VAALCO能源是一家从事油气勘探开发的能源企业，公司注册于美国特拉华州，总部位于德克萨斯州休斯顿，核心业务区块位于加蓬近海的埃塔姆马林区块。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
EGY vs PBYI — 直观对比
营收规模更大
EGY
是对方的1.2倍
$75.5M
营收增速更快
PBYI
高出52.9%
-25.2%
两年增速更快
PBYI
近两年复合增速
-4.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $91.0M | $75.5M |
| 净利润 | $-58.6M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | -71.3% | 22.7% |
| 净利率 | -64.4% | — |
| 营收同比 | -25.2% | 27.7% |
| 净利润同比 | -602.5% | — |
| 每股收益（稀释后） | $-0.56 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EGYPBYI
| Q4 25 | $91.0M | $75.5M | ||
| Q3 25 | $61.0M | $54.5M | ||
| Q2 25 | $96.9M | $52.4M | ||
| Q1 25 | $110.3M | $46.0M | ||
| Q4 24 | $121.7M | $59.1M | ||
| Q3 24 | $140.3M | $80.5M | ||
| Q2 24 | $116.8M | $47.1M | ||
| Q1 24 | $100.2M | $43.8M |
净利润EGYPBYI
| Q4 25 | $-58.6M | — | ||
| Q3 25 | $1.1M | $8.8M | ||
| Q2 25 | $8.4M | $5.9M | ||
| Q1 25 | $7.7M | $3.0M | ||
| Q4 24 | $11.7M | — | ||
| Q3 24 | $11.0M | $20.3M | ||
| Q2 24 | $28.2M | $-4.5M | ||
| Q1 24 | $7.7M | $-4.8M |
毛利率EGYPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率EGYPBYI
| Q4 25 | -71.3% | 22.7% | ||
| Q3 25 | 1.5% | 17.6% | ||
| Q2 25 | 17.7% | 12.7% | ||
| Q1 25 | 23.7% | 8.7% | ||
| Q4 24 | 32.7% | 22.6% | ||
| Q3 24 | 31.4% | 27.4% | ||
| Q2 24 | 17.5% | -4.6% | ||
| Q1 24 | 32.1% | -5.3% |
净利率EGYPBYI
| Q4 25 | -64.4% | — | ||
| Q3 25 | 1.8% | 16.2% | ||
| Q2 25 | 8.6% | 11.2% | ||
| Q1 25 | 7.0% | 6.5% | ||
| Q4 24 | 9.6% | — | ||
| Q3 24 | 7.8% | 25.2% | ||
| Q2 24 | 24.1% | -9.6% | ||
| Q1 24 | 7.7% | -11.0% |
每股收益（稀释后）EGYPBYI
| Q4 25 | $-0.56 | $0.26 | ||
| Q3 25 | $0.01 | $0.17 | ||
| Q2 25 | $0.08 | $0.12 | ||
| Q1 25 | $0.07 | $0.06 | ||
| Q4 24 | $0.12 | $0.40 | ||
| Q3 24 | $0.10 | $0.41 | ||
| Q2 24 | $0.27 | $-0.09 | ||
| Q1 24 | $0.07 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $58.9M | $97.5M |
| 总债务越低越好 | $60.0M | $22.7M |
| 股东权益账面价值 | $443.5M | $130.3M |
| 总资产 | $913.4M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.14× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资EGYPBYI
| Q4 25 | $58.9M | $97.5M | ||
| Q3 25 | $24.0M | $94.4M | ||
| Q2 25 | $67.9M | $96.0M | ||
| Q1 25 | $40.9M | $93.2M | ||
| Q4 24 | $82.7M | $101.0M | ||
| Q3 24 | $89.1M | $96.7M | ||
| Q2 24 | $62.9M | $96.8M | ||
| Q1 24 | $113.3M | $107.2M |
总债务EGYPBYI
| Q4 25 | $60.0M | $22.7M | ||
| Q3 25 | $60.0M | $34.0M | ||
| Q2 25 | $60.0M | $45.3M | ||
| Q1 25 | $0 | $56.7M | ||
| Q4 24 | $0 | $68.0M | ||
| Q3 24 | $0 | $79.3M | ||
| Q2 24 | $0 | $90.7M | ||
| Q1 24 | $0 | $102.0M |
股东权益EGYPBYI
| Q4 25 | $443.5M | $130.3M | ||
| Q3 25 | $505.9M | $115.3M | ||
| Q2 25 | $511.6M | $104.7M | ||
| Q1 25 | $504.1M | $97.1M | ||
| Q4 24 | $501.6M | $92.1M | ||
| Q3 24 | $501.0M | $71.1M | ||
| Q2 24 | $493.6M | $48.5M | ||
| Q1 24 | $472.6M | $51.0M |
总资产EGYPBYI
| Q4 25 | $913.4M | $216.3M | ||
| Q3 25 | $950.4M | $202.9M | ||
| Q2 25 | $964.9M | $194.9M | ||
| Q1 25 | $927.1M | $196.2M | ||
| Q4 24 | $955.0M | $213.3M | ||
| Q3 24 | $937.9M | $220.7M | ||
| Q2 24 | $917.4M | $205.0M | ||
| Q1 24 | $809.1M | $214.1M |
负债/权益比EGYPBYI
| Q4 25 | 0.14× | 0.17× | ||
| Q3 25 | 0.12× | 0.30× | ||
| Q2 25 | 0.12× | 0.43× | ||
| Q1 25 | 0.00× | 0.58× | ||
| Q4 24 | 0.00× | 0.74× | ||
| Q3 24 | 0.00× | 1.12× | ||
| Q2 24 | 0.00× | 1.87× | ||
| Q1 24 | 0.00× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $145.2M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流EGYPBYI
| Q4 25 | $145.2M | $14.4M | ||
| Q3 25 | $16.4M | $9.7M | ||
| Q2 25 | $18.3M | $14.1M | ||
| Q1 25 | $32.7M | $3.6M | ||
| Q4 24 | $44.5M | $15.6M | ||
| Q3 24 | $47.8M | $11.0M | ||
| Q2 24 | $-438.0K | $1.0M | ||
| Q1 24 | $21.8M | $11.2M |
自由现金流EGYPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | $29.7M | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率EGYPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | 26.9% | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度EGYPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | 2.7% | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率EGYPBYI
| Q4 25 | — | — | ||
| Q3 25 | 14.94× | 1.10× | ||
| Q2 25 | 2.19× | 2.41× | ||
| Q1 25 | 4.23× | 1.21× | ||
| Q4 24 | 3.82× | — | ||
| Q3 24 | 4.35× | 0.54× | ||
| Q2 24 | -0.02× | — | ||
| Q1 24 | 2.84× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EGY
| Crude Oil Sales And Purchase Agreements | $54.8M | 60% |
| Other | $31.9M | 35% |
| Crude Oil | $3.0M | 3% |
| Natural Gas Liquids Reserves | $1.4M | 2% |
PBYI
暂无分部数据
